The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million 1) ...
Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) progressing towards closing which will result in a differentiated company ...
Proposed combination with Clywedog Therapeutics Inc. ("Clywedog") progressing towards closing which will result in a differentiated company focusing on metabolic and autoimmune pipeline assets with mu ...
European STOXX Europe 600 Index shows a positive trend with a weekly gain of 1.91%, driven by corporate earnings and geopolitical developments, investors are closely watching how these factors might ...
Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. engages in the manufacture and distribution of Chinese medicines and pharmaceutical products. Its products include Edaravone Injection, Compound ...
MBX Biosciences targets endocrine and metabolic disorders with novel peptide therapies, advancing candidates across several ...
About Bio Green Med Solution Inc. Bio Green Med Solution, Inc. which engages in the supply and trading of protective and fire safety equipment to commercial, industrial, healthcare, and residential ...
Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a clinical-stage biopharmaceutical company developing drugs for ...
In February 2026, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in REGENXBIO Inc. v. Sarepta Therapeutics, ...
Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight The chronic obstructive pulmonary disease clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results